(Press-News.org)
When a patient is experiencing heart failure, a leading cause of death worldwide, they begin to lose healthy and functioning cardiac cells. Heart failure causes these once-flexible cells to develop into fibrotic cells that are no longer able to contract and relax. This stiffening of the cardiac cells compromises their ability to carry blood efficiently to the rest of the organs in the human system. Because humans cannot regenerate these cardiac cells, the patient faces a long road to recovery marked by preventative or symptomatic treatments.
However, some mammals do have the ability to regenerate cardiac cells, though generally for a specific amount of time immediately following birth. With that in mind, Mahmoud Salama Ahmed, Ph.D., and an international team of researchers have completed an investigation to uncover novel therapeutics or existing therapeutic regimens previously approved by the Food and Drug Administration (FDA) for cardiac regeneration. Their study (“Identification of FDA-approved drugs that induce heart regeneration in mammals”) was published in March in Nature Cardiovascular Research.
“This is a study for regenerative therapy more than symptomatic treatment,” Ahmed added.
Ahmed, a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, worked on the study while at UT Southwestern Medical Center. He said the current research is based upon findings from a 2020 study (https://www.nature.com/articles/s41586-020-2228-6) from the UT Southwestern Medical Center laboratory of Hesham Sadek, M.D., Ph.D.
In that study, investigators demonstrated that mice can indeed regenerate cardiac cells upon genetic deletion of two transcription factors: Meis1 and Hoxb13. Armed with that information, Ahmed and his collaborators started their latest study in 2018 at UT Southwestern Medical Center. They began by targeting the transcription factors (Meis1 and Hoxb13) using paromomycin and neomycin, two antibiotics from the aminoglycoside class.
“We developed inhibitors to switch off the internal transcription and restore the regenerative capacity of cardiac cells,” Ahmed added.
Ahmed said the structure scaffold of paromomycin and neomycin indicated they had the potential to bind to and inhibit the Meis1 transcription factor. To understand how the binding might occur, the team first had to uncover the molecular mechanisms of paromomycin and neomycin and learn how they bind to Meis1 and Hoxb13 genes.
“We started testing in mice suffering from myocardial infarction or ischemia,” Ahmed explained. “We found that both of them (paromomycin and neomycin) work synergistically with each other to elevate the ejection fraction (the percentage of blood leaving the heart each time it pumps), so the contractility of the ventricles (heart chambers) is significantly improved. It enhanced the cardiac output and reduced the fibrotic scar that was getting down into the heart.”
The team collaborated with scientists from the University of Alabama at Birmingham to administer paromomycin and neomycin to pigs suffering from myocardial infarction. They discovered the pigs suffering from myocardial infarction had better contractility, ejection fractions and overall improved cardiac output when they were administered the paromomycin and neomycin.
In future research, Ahmed is interested in combining the binding profiles of paromomycin and neomycin into one molecule rather than two. If successful, he said the new molecule will be able to avoid any adverse or potentially adverse effects associated with antibiotic resistance.
“We want to have newly synthesized small molecules targeting Meis1 and Hoxb13,” Ahmed said. “We want to go forward for further investigation in pigs regarding toxicological studies. Later on, hopefully this will be an introduction for clinical trials in humans. The good thing about that is we are using a couple of FDA-approved drugs with established safety profiles and well-known side effects, so we are cutting out some milestones regarding gaining approval for the investigation of a new drug. This is the beauty of drug repurposing: We can go to the clinic earlier so we can begin to rescue some lives.”
###
END
Vanilla extract is one of the most widely used flavoring compounds in food products and cosmetics. The pleasant and sweet smell of this classic flavor is imparted by the chemical compound ‘vanillin’ found in the seed pods of vanilla plants belonging to the orchid family. In plants, vanillin is synthesized by the conversion of ferulic acid by the enzyme - VpVAN. However, laboratory biosynthesis of vanillin from plant-derived VpVAN yields only very small quantities of vanillin, and is, therefore, commercially impractical. Further, although chemically derived ...
NEW YORK, NY — Perceiving something – anything – in your surroundings is to become aware of what your senses are detecting. Today, Columbia University neuroscientists identify, for the first time, brain-cell circuitry in fruit flies that converts raw sensory signals into color perceptions that can guide behavior.
Their findings were pulbished in the journal Nature Neuroscience.
“Many of us take for granted the rich colors we see every day – the red of a ripe strawberry ...
After spinning for under two years, a wind farm can offset the carbon emissions generated across its entire 30-year lifespan, when compared to thermal power plants.
That’s according to a new peer-reviewed study published in the Journal of the Royal Society of New Zealand – which also shows within six months a turbine can generate all the energy consumed across its life-cycle.
The research uses data from the Harapaki onshore wind farm in Hawke’s Bay, New Zealand – however the authors of the paper explain that their findings would be replicated across most, if not all, wind farms internationally.
“The wind turbine technology employed in New Zealand ...
One in three people around the world die from cardiovascular disease, which is mainly caused by atherosclerosis. This makes atherosclerosis the leading cause of death globally. Additionally, many people live with serious manifestations of atherosclerosis, for example, following a heart attack or a stroke.
Atherosclerosis not only represents a significant burden for these individuals, but also a heavy burden on healthcare systems and societies in all parts of the world.
“Atherosclerosis may develop from an early age and often remains 'silent’, that is, without symptoms, ...
While ethanol in alcoholic beverages impairs drinkers’ motor functions, it is that same substance that can power motor vehicles in a cleaner, more sustainable manner. What is necessary for the production of ethanol is yeast, but ethanol is among the environmental factors that add stress to yeasts, hindering their growth. To promote efficient bioethanol production, scientists have been searching for substances that can help yeasts better withstand ethanol, but few effective ones have been found.
An Osaka Metropolitan ...
Fukuoka, Japan—Researchers at Kyushu University have published a comprehensive analysis on the carbon footprint of constructing a wooden house in Japan. The study covered the total amount of emissions produced, taking into consideration the entire supply chain including the processing and transport of the raw materials that go into building a house.
The team hopes that by identifying emission hot spots in the supply chain that go into building a house, policy makers can implement strategies to reduce its climate impact. Their analysis was published in the Journal of Environmental ...
Scientists at the University of Oregon have discovered that colonies of gelatinous sea animals swim through the ocean in giant corkscrew shapes using coordinated jet propulsion, an unusual kind of locomotion that could inspire new designs for efficient underwater vehicles.
The research involves salps, small creatures that look similar to jellyfish that take a nightly journey from the depths of the ocean to the surface. Observing that migration with special cameras helped UO researchers and their colleagues capture the macroplankton’s graceful, coordinated swimming behavior.
“The largest migration on the planet ...
New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT).
At the height of the COVID-19 pandemic in 2021,VITT emerged as a new disease following adenovirus vector-based vaccines – notably the Oxford-AstraZeneca vaccine.
VITT was found to be caused by an unusually dangerous blood autoantibody directed against a protein termed platelet factor 4 (or PF4).
In separate research in 2023, ...
BATON ROUGE – Ochsner Baton Rouge has opened the new Ochsner Outpatient and Home Infusion Pharmacy – Baton Rouge at 4730 Bluebonnet Blvd., Suite 401. This advanced facility provides treatment for chronic, specialty and acute home infusions.
The pharmacy is conveniently located and designed with patient comfort and accessibility in mind. Each of its six patient rooms offers a spa-like environment, providing patient care in a peaceful, supportive setting that promotes healing. Ochsner’s pharmacists work closely with patients’ healthcare providers to create customized treatment plans, ensuring personalized and effective ...
Key takeaways
A new study by UCLA sociologists found that using the word “please” does not always indicate respect or politeness.
In the study, “please” was used only 7% of the time, mostly when there was an inhospitable interactional environment to overcome.
Findings will help researchers in their understanding of politeness in the flow of social behavior and norms.
By kindergarten age, most children have been taught that “please” is a magic word. “Please” is an expression of politeness that shows courtesy and respect, turning a potential demand into a request that will – ...
